IGF binding protein-4 (IGFBP-4) proteolytic degradation is
O VINE, BOVINE, PORCINE, equine, and human preovulatory ovarian follicles are characterized by a high proteolytic activity degrading IGF binding protein-4 (IGFBP-4). More precisely, Besnard et al. (1, 2) have shown that follicular growth and atresia are characterized by an increase and decrease, respectively, in intrafollicular proteolytic activity degrading IGFBP-4 in the ewe and sow. Chandrasekher et al. (3) have also shown the presence of a proteolytic activity degrading IGFBP-4 in follicular fluid from human dominant estrogenic but not atretic follicles. In all species studied, the intrafollicular protease degrading IGFBP-4 has been shown to belong to the metalloprotease superfamily, to be IGF dependent, and to be inhibited by heparin-binding domain-containing peptides (1) (2) (3) (4) (5) (6) . These properties were also reported for IGFBP-4 proteases studied in numerous cell culture media (7) . Although several studies have dealt with regulation of IGFBP-4 proteolytic degradation in ovarian follicular fluid or in conditioned media, the protease involved in IGFBP-4 degradation was unknown (4 -8) .
An IGFBP-4-specific protease produced by human fibroblasts and osteoblasts cells in culture was recently identified as pregnancy-associated plasma protein-A (PAPP-A) (9) . PAPP-A is a large dimeric glycoprotein of 400 kDa. During pregnancy, it circulates in increasing concentrations as a 2:2 disulfide-bound complex of 500 kDa with the proform of eosinophil major basic protein (proMBP), denoted PAPP-A/ proMBP (10, 11) . Because proMBP is not visible in Coomassie-stained gels (10) , this component was overlooked in earlier preparations of the protein (12, 13) . As a consequence, preparations of polyclonal antibodies against PAPP-A isolated from pregnancy serum is in fact anti-PAPP-A/proMBP, also recognizing proMBP (10) . Antigen recognized by such preparations was previously shown to be present in the human ovary (14 -17) , and synthesis of both PAPP-A and proMBP mRNA in the human ovary has been demonstrated by RT-PCR (18) . Using monoclonal antibodies specific for PAPP-A only, the presence of PAPP-A was recently confirmed in human preovulatory follicular fluid, and PAPP-A was identified as the protease responsible for IGFBP-4 degradation (19) .
The aims of this study were to determine whether PAPP-A is involved in IGFBP-4 proteolytic degradation in ovine, bovine, porcine, and equine ovarian follicles, and to study mRNA expression in granulosa cells from different classes of follicles in comparison with mRNA expression of LH receptor and aromatase mRNAs.
Materials and Methods Materials
Fluorogestone acetate sponges used to synchronize ovine estrous cycles and PMSG was obtained from Intervet (Angers, France). Altrenogest was obtained from Roussel-Uclaf (Romainville, France). Norgestomet implant was obtained from Intervet. Estrumate was obtained from Pitman-Moore (Meaux, France). Detomidine and prifinium bromide (Prifinial) were obtained from SmithKline & French (Courbevoie, France) and Vetoquinol (Lure, France), respectively. Mixtencilline, penicillin, and dihydrostreptomycin were obtained from Rhô ne-Mérieux (Lyon, France). IGF-I and IGF-II were generous gifts from Dr. H. H. Peter and Dr. A. Hinnen (Ciba-Geigy, Basel, Switzerland). Recombinant human IGFBP-4 was expressed in yeast and purified as previously described (20) . Recombinant human PAPP-A (rhPAPP-A) was expressed in HEK 293 cells and purified as previously described (21 (27) . Human IGFBP-4 C-terminal and N-terminal purified proteolytic fragments were kindly provided by Ständker (Hannover, Germany) (28) . Rabbit polyclonal antiserum against human IGFBP-4 was purchased from Ubi (Lake Placid, NY). Antirabbit IgG antibodies coupled to horseradish peroxidase were purchased from DAKO Corp. (Trappes, France). Rabbit polyclonal anti-PAPP-A/proMBP) (Overgaard M.T., C. Christiansen, and C. Oxvig, unpublished data) was raised against PAPP-A/proMBP purified from pregnancy serum (11 (Gaithersburg, MD) and random hexamers from Pharmacia (Uppsala, Sweden).
Animals and treatment
All procedures were approved by the agricultural and scientific research agencies (approval number A37801) and conducted in accordance with the guidelines for Care and Use of Agricultural Animals in Agricultural Research and Teaching.
Ewe. Four adult Romanov and Ile-de-France ewes were treated with progestogen (intravaginal fluorogestone acetate sponges, 40 mg) for 15 d to synchronize estrus. They were injected with 500 IU PMSG 30 h before sponge removal. Twenty-four hours after sponge removal, ovaries were collected by castration. Only large follicles (5-7 mm in diameter) were recovered. Preovulatory follicular fluid was aspired by puncture and individually stored at Ϫ20 C.
Sows. Six cyclic adult Pietrain x Large-White sows were synchronized by daily feeding of 20 mg Altrenogest for 15 d, as previously described (2) . Ovaries were carefully dissected and collected by castration 24 h (beginning of follicular phase), 96 h (middle of follicular phase), and 120 h (end of follicular phase) after progestin withdrawal. Follicles were classified according to their size: small (3-4 mm), medium (5-6 mm), and large (7-8 mm) (see below). Between 10 and 15 follicles from each class were recovered.
Heifers. Estrus cycles were synchronized in 2 Holstein heifers with a Norgestomet implant for 10 d. Twelve days after detection of estrus (day 0 ϭ day of estrus), the heifers were treated with two injections of 2000 IU PMSG and 2 injections of 25 mg im PGF 2␣ analog (Estrumate) and were killed at day 14. Follicles were carefully dissected and classified according to their size: small (4 -6 mm), medium (10 -12 mm), and large (15-20 mm) (see below). Approximately 5-10 follicles from each class were recovered.
Mares. Twelve cyclic Welsh pony mares were treated with 125 g PGF 2␣ analog (Estrumate) during the midluteal phase to induce luteolysis. Ovarian activity was then assessed by routine transrectal ultrasonic imaging (Aloka 210 with a 5-Mhz linear probe; Société Bernard, Nantes, France), as previously described (29) . Follicle diameter was estimated by averaging two cross-sectional measures of follicles, and follicular morphology was judged by the presence or absence of echogenic dots in follicular antrum. One healthy growing follicle per animal was punctured at the end of the follicular stage (33-35 mm). Follicular fluid was aspirated by transvaginal ultrasound-guided follicular puncture with a 7.5-Mhz sectorial probe (Kretz, Soframed, Truchtersheim, France) coupled to a sterile single lumen needle (60 cm long; Thiébaud Frères, Jouvernex Margencel, France), as previously described (30, 31) . Before each puncture session, mares were sedated by a single injection of 0.2 ml detomidine iv [Domosédan, 1 mg/100 kg body weight (BW)]. Prifinium bromide (Prifinial) was injected (15 ml iv, 45 mg/100 kg BW) to ensure rectal relaxation. After puncture sessions, the mares were injected with antibiotics (20 ml im Mixtencilline; 1,600,000 IU penicillin/100 kg BW and 1.3 g dihydrostreptomycine/100 kg BW).
Classification of bovine and porcine follicles used for RNA extraction. In the heifer and the sow, follicles of different sizes were classified according to their quality. For this purpose, follicular fluids were aspired by puncture and individually stored at Ϫ20 C. Each follicle was then slit open in B2 medium, and a suspension of granulosa cells was prepared and stored at Ϫ70 C, as described previously (32) . For each suspension, a smear of granulosa cells was performed on histological slides, fixed in methanol-formaldehyde-acetic acid (80:15:5), and subsequently stained with Feulgen. The quality of each follicle was assessed by microscopic examination of smears using classical histological criteria; follicles were judged normal (frequent mitosis, no pyknosis in granulosa cells) or atretic (no mitosis, numerous pyknotic bodies in granulosa cells). Furthermore, follicular fluids were analyzed individually by Western ligand blotting (WLB). In particular, as previously described (29, (33) (34) (35) , ovine, porcine, bovine, and equine large follicles characterized by the presence of IGFBP-3; the absence of IGFBP-2, -4, and -5; and a high proteolytic activity degrading IGFBP-4 in follicular fluid were considered as preovulatory, whereas follicles characterized by high levels of IGFBP-2, -4, and -5 (heifers) were considered as early and late atretic follicles, respectively. The rest of granulosa cells of each bovine and porcine follicle was individually stored at Ϫ20 C before RNA extraction.
Degradation of IGFBP-4 by follicular fluid and by rhPAPP-A.
Two microliters porcine or bovine preovulatory follicular fluid or different concentrations of rhPAPP-A were incubated in a solution of 20 mm Tris (pH 7.6) containing 137 mm NaCl (TBS) and 0.1% BSA with IGFBP-4, with or without IGF-I for 20 h at 37 C (final volume, 10 l). In some experiments, the synthetic peptides P3, P5, CTGF 247-260 , VN, p36 subunit, or HIP were added to the incubation medium. At the end of the incubation, samples were analyzed by WLB or immunoblotting, as previously described (4, 5, 33) .
Immunoneutralization and immunodepletion of IGFBP-4 proteolytic degradation.
For immunoneutralization, 2 l of preovulatory follicular fluid were incubated in TBS containing 0.1% BSA, 20 ng of IGFBP-4, and different dilutions of rabbit PAPP-A polyclonal antibody or nonspecific rabbit IgG or glycerol for 20 h at 37 C (final volume, 10 l). At the end of the incubation, samples were analyzed by WLB. For immunodepletion, PAPP-A polyclonal antibody or nonspecific rabbit IgG was used in conjunction with protein G-plus/protein-A-agarose to immunoprecipitate IGFBP-4 protease activity. The supernatants were then studied for their ability to degrade [
125 I]IGFBP-4, as previously described (19) .
RNA extraction. Total RNAs from granulosa cells of individually dissected bovine and porcine follicles were prepared according to Chomczynsky and Sacchi (36) using acid guanidinium thiocyanate-phenolchloroform extraction. Total RNAs were quantified by measuring the absorbance at 260 nm. Samples were stored at Ϫ70 C until used. RNAs from some follicles (particularly small and atretic follicles) were pooled according to their size and quality to obtain sufficient amounts to perform real-time RT-PCR experiments. RNAs were also extracted from granulosa cells of ovine and equine preovulatory follicles for RT-PCR and sequencing of cDNA fragments of PAPP-A in these species.
Isolation and sequencing of ovine, bovine, porcine, and equine PAPP-A cDNA fragments. A cDNA fragment from bovine PAPP-A was isolated by RT-PCR by using the upper primer U1 and the lower primer L1 derived from the nucleotide sequence of human PAPP-A (37) ( Table 1 ). Then two other pairs of primers (U2-L2 and U3-L2) were chosen on the basis of both human and bovine sequence to amplify ovine, porcine, and equine cDNA ( Table 1) . Reverse transcription was performed during 1 h at 37 C in a total volume of 25 l with 3 g total ovarian RNAs as template, 1.5 mm dNTP, reverse transcriptase buffer 5ϫ, 20 U Rnase inhibitor, 3.2 m lower prime, and 200 U Moloney murine leukemia virus reverse transcriptase. The resulting cDNA was subjected to PCR. PCR was performed in a total volume of 50 l with 1 U AmpliTaq polymerase, CCAGTCAGTGGAGACAAAGGT Human/bovine 2181-2161 * U1, L1 were derived from the human PAPP-A sequence (GenBank accession number: X68280 [37] . U2, U3, L2 were chosen according to human and bovine sequences. Denaturation, annealing, and extension were performed at 94 C for 1 min, 57 C for 1 min 30 sec, and 72 C for 1 min 30, respectively, on a geneAmpPCR System 9700. PCR products at the expected size were extracted from agarose using the gel extraction kit QIAquick (QIAGEN, Hilden, Germany). They were sequenced in both directions with several primers. croliters of the PCR reactions were analyzed on 1% agarose gel. Each hybrid was then scored for the presence of a pig specific DNA fragment and the assignments were performed, using software that calculates the probability of the localization of a marker among the 115 regions of the porcine genome determined by this panel (http://www.toulouse. inra.fr/lgc/pig/hybrid.htm). For the localization on the irradiated panel, we used the Institut National de la Recherche AgronomiqueMinnesota Porcine Radiation Map (ImpRH) panel (7000 rads) developed by Yerle et al. (38) , including 118 hybrid clones. For RH mapping, the same PCR conditions and detection methods as described above were used. The results were analyzed with the ImpRH mapping tool developed by Milan et al. (39) . This enables mapping of markers in relation to previously localized markers of the first-generation map (40) .
Localization of the porcine PAPP-

Real-time RT-PCR.
Real-time quantitative PCR analyses for bovine and porcine PAPP-A, LH receptor, and P450 aromatase were performed on total RNAs from granulosa cells, using an ABI PRISM 7700 sequence detection system instrument and software (PE Applied Biosystems, Cortaboeuf, France). It was performed using specific primers presented in Table 2 . Each transcript level of target genes (aromatase, LH receptor, and PAPP-A) was normalized on the basis of level of transcripts for the constitutive housekeeping gene product 36B4 coding for acidic ribosomal phosphoprotein (PO) (41) or the constitutive housekeeping gene coding for the TBP (TATA box-binding protein, a component of the DNA-binding protein complex TFIID) (42) . They were measured to control the differences in RNA concentration between each sample. Bovine and porcine TBP and PO genes were partially sequenced to design the specific primers presented in Table 2 . No difference in PO and TBP RNA levels was observed between healthy and atretic follicles: For each sample, the ratio PO mRNA expression level/TBP mRNA expression level ϭ 1. So these two genes were considered efficient endogenous control genes. In each case, RNAs were reverse transcribed in a final volume of 20 l containing 1ϫ reverse transcription buffer (500 mm each dNTP, 3 mm MgCl 2 , 75 mm KCl, and 50 mm Tris-HCl, pH 8.3), 10 U of RNAsin ribonuclease inhibitor, 10 mm dithiothreitol, 50 U of SuperScript II Rnase H reverse transcriptase, 1.5 mm random hexamers, and 1 g total RNA. Amplification reaction were then performed using the SYBRGreen PCR core reagents kit (PE Applied Biosystems). The thermal cycling conditions comprised an initial denaturation step at 95 C for 10 min and 50 cycles at 95 C for 15 sec and 65 C for 1 min. Experiments were performed with duplicates for each data point. Levels of PAPP-A, LH receptor, and aromatase mRNA were expressed as a ratio to PO or TBP mRNA values.
Quantification of WLB. WLB was quantified by a PhosphorImager (Storm/ImageQuant, Molecular Dynamics, Inc., Sunnyvale, CA). Quantification was performed as previously described (1) . Briefly, the amount of radiolabeled IGF-II bound to each IGFBP was expressed as the inte- Statistical analysis. Multiple comparisons of means of inhibition of IGFBP-4 proteolytic degradation without or with increasing concentrations of PAPP-A polyclonal antibodies or with increasing concentrations of peptides P3 and P5 were performed by ANOVA test followed by Tukey's multiple comparison test. Means of inhibition of IGFBP-4 proteolytic degradation by peptides HIP, VN1, VN3, VN5, and CTGF were compared with 0 (absence of inhibition of IGFBP-4 degradation without peptides) by a paired t test. Comparisons with P values more than 0.05 were not considered significant. Simple correlation coefficient (Pearson) was calculated to assess relationship among PAPP-A, aromatase, and LH receptor gene expression (Prism, GraphPad Software, San Diego, CA). An r value with a value of P more than 0.05 was considered nonsignificant.
Results
Immunoneutralization and immunodepletion of IGFBP-4-degrading protease in preovulatory follicular fluid
As previously described and as shown in Fig. 1A (lane 2  vs. lane 1) , ovine, bovine, porcine, and equine preovulatory follicular fluid contained IGFBP-4-degrading proteolytic activity (4, 5) . Coincubation of follicular fluid with polyclonal antibody against human PAPP-A, but not rabbit IgG, inhibited in a dose-dependent manner IGFBP-4 proteolytic degradation in the four species (Fig. 1) . Moreover, PAPP-A polyclonal antibodies were able to immunodeplete intrafollicular IGFBP-4 proteolytic activity from the four species as well (Fig. 2) .
Comparison of pattern of IGFBP-4 degradation by preovulatory follicular fluid and by rhPAPP-A
Incubation of IGFBP-4 with rhPAPP-A as well as with porcine, ovine, bovine, and equine preovulatory follicular fluid generated 17-and 10-kDa proteolytic fragments corresponding to the N-and the C-terminal proteolytic fragments of IGFBP-4 (Fig. 3) . Moreover, in a recent work, we have shown that addition of IGF-I or IGF-II to follicular fluid from ovine, bovine, porcine, and equine preovulatory follicles enhanced IGFBP-4 degradation (4, 5). In the same conditions, IGF-I and IGF-II also enhanced IGFBP-4 degradation by rh-PAPP-A in a dose-dependent manner (data not shown, 21). Recently we have also shown that synthetic peptides containing a heparin-binding domain derived from IGFBP-3 (P3), IGFBP-5 (P5), VN, CTGF, or HIP were able to inhibit intrafollicular IGFBP-4 proteolytic degradation. Similarly, rhPAPP-A activity was inhibited by P3, P5, CTGF 247-260 , VN1, VN3, and, with less efficiency, by HIP (Figs. 4 and 5) . As in follicular fluid, p36 annexin subunit-derived peptide and VN5 had no effect on rhPAPP-A activity.
Sequences of cDNA fragment of ovine, bovine, porcine, and equine PAPP-A
RNAs from granulosa cells of the four species were used as a template to amplify fragments of cDNA of PAPP-A by RT-PCR. The alignment of ovine, bovine, porcine, equine, and human PAPP-A sequences with that of human PAPP-A is shown in Fig. 6 . The sequence is highly conserved in all these species. In particular, a high degree of conservation is observed among the human, bovine, and ovine sequence encompassing the zinc-binding domain. 
Localization of the porcine PAPP-A gene on the porcine genome
The primers designed on the porcine PAPP-A sequence enabled the amplification of a 130-bp specific DNA with porcine genomic DNA and no amplification with mouse or hamster DNA. Using the somatic cell hybrid panel, the PAPP-A gene was localized on either chromosome 1q18 or 1q28-q213 region, with an equal probability of 0.444, a correlation coefficient of 0.8367, and an error risk lower than 0.5%. The localization on the ImpRH panel showed a linkage of PAPP-A gene with marker SW1957 (LOD score ϭ 10.12). This is in favor of a localization of the PAPP-A gene at the end of the long arm of chromosome 1 (1q29 -1q213), according to the markers mapped on both cytogenetic and genetic maps (http:/ /fabctr.umn.edu/ RHmaps/chromosome/chromosome1.html).
Expression of mRNA of PAPP-A, aromatase, and LH receptor from bovine and porcine follicles of different classes
We have previously shown that intrafollicular proteolytic activity degrading IGFBP-4 increases during follicular growth to reach a maximum in preovulatory follicles (1, 2). So we have investigated whether this increase is associated with an increase in PAPP-A mRNA expression in granulosa cells during follicular growth and whether there is a correlation between expression of PAPP-A mRNA and expression of two well-known markers of follicular growth, aromatase, and LH receptor. Quantitative RT-PCR showed that expression of PAPP-A mRNA was highest in granulosa cells from bovine and porcine fully differentiated follicles in comparison with immature and atretic follicles. Moreover, expression of PAPP-A mRNA was closely correlated with expression of aromatase and LH receptor genes in both species (Fig.  7) . Similar results were obtained by using either PO or TBP as endogenous RNA control ( Table 3 ). The intrafollicular IGFBP-4 proteolytic degradation was also correlated with the level of PAPP-A RNAs (Fig. 7 and Table 3 ).
Discussion
In the present work, we have shown that PAPP-A is involved in IGFBP-4 degradation in ovine, bovine, porcine, and equine preovulatory follicles. Indeed, antibodies against human PAPP-A were shown to neutralize and to immunodeplete intrafollicular IGFBP-4 proteolytic activity. Furthermore, rhPAPP-A and intrafollicular IGFBP-4 degrading protease exhibited similar properties: 1) both generated proteolytic fragments of identical sizes after incubation with IGFBP-4; and 2) in both cases, IGFBP-4 degradation was enhanced by IGFs and inhibited by peptides containing a heparin-binding domain. PAPP-A sequences showed high degree of homology between all mammalian species. Moreover, the PAPP-A gene has been localized on porcine chromosome 1 (1q29 -1q213), in agreement with the localization of the human PAPP-A gene on human chromosome 9q33.1. Furthermore, we have investigated whether the known increase in IGFBP-4 proteolytic degradation during follicular growth (1, 2) was associated with an increase in PAPP-A mRNA expression in granulosa cells and whether there was a correlation between expression of PAPP-A mRNA and expression of two well-known markers of follicular growth, aromatase, and LH receptors. In bovine and porcine granulosa cells, PAPP-A mRNA expression level was shown to be maximal in differentiated follicles and highly correlated to aromatase and LH receptor expression.
Overall, these results suggest that degradation of IGFBP-4 by PAPP-A in preovulatory follicles is a well-conserved mechanism in mammalian species. The coexpression of PAPP-A and aromatase and LH receptors in granulosa cells of preovulatory follicles suggest that PAPP-A could be considered a marker of follicular development. Of note, PAPP-A and proMBP mRNA expression in the ovary have been previously observed by Overgaard et al. (18) . By in situ hybridization, Hourvitz et al. (43) have recently shown that PAPP-A was expressed in granulosa cells of healthy follicles from 5 mm antral to the preovulatory stage in human ovary. In vitro, FSH has been shown to stimulate IGFBP-4 degradation in rat and human granulosa cell culture (44 -46) . PAPP-A protein has also been recently detected in conditioned media from human granulosa derived from estrogen-dominant but not androgen-dominant follicles (47) . Overall, these data suggest that PAPP-A expression in the ovary is restricted to granulosa cells of healthy dominant follicles. However, there is no evidence that PAPP-A mRNA expression is FSH dependent in the ovary. Progesterone could also be proposed as a modulator of PAPP-A secretion. Indeed, Sjöberg et al. (16) have found a positive correlation between intrafollicular PAPP-A level and progesterone concentration in human hyperstimulated follicles. In addition, PAPP-A mRNA and protein have been localized in corpus luteum and in luteinized granulosa cells in humans (16, 43) . Further investigations are needed now to identify the factors regulating the expression of PAPP-A in the ovary.
In the present work, quantitative RT-PCR has shown that PAPP-A mRNA expression is detectable in some immature and atretic follicles in which no proteolytic activity degrading IGFBP-4 is observed, suggesting that the activity of residual PAPP-A is impaired. In particular, we have recently shown that in early atretic follicles, the decrease in IGF bioavailability, owing to the increase in IGFBP-2, may indirectly contribute to the decrease in IGFBP-4 degradation (4, 5). Moreover, in late atretic ovine and bovine follicles, the increase in peptides containing the heparin-binding domain from IGFBP-5 (following a dramatic increase in expression level) and from the C-terminal proteolytic fragment of IGFBP-3 (following an increase in proteolytic degradation) would strengthen the inhibition of IGFBP-4 degradation (4, 5) . Further investigations are necessary to test whether bovine individually dissected follicles. Endogenous gene control: TBP. Heifer: E, healthy follicles 4 -6 mm (n ϭ 4); Ⅺ, healthy follicles 10 -12 mm (n ϭ 4); ‚, healthy follicles 15-20 mm (n ϭ 5); F, early atretic follicles 4 -6 mm (n ϭ 3); f, early atretic follicles 10 -12 mm (n ϭ 3); OE, early atretic follicles 15-20 mm (n ϭ 3); ϩ, late atretic follicles 4 -6 mm (n ϭ 3); x, late atretic follicles 10 -12 mm (n ϭ 3). Sow: E, healthy follicles 3-4 mm (n ϭ 5); Ⅺ, healthy follicles 5-6 mm (n ϭ 7); ‚, healthy follicles 7-8 mm (n ϭ 7); F, atretic follicles 3-4 mm (n ϭ 6); f, atretic follicles 5-6 mm (n ϭ 5). In the present case, the level of expression of the target gene (PAPP-A, aromatase, LH receptor) was expressed as a ratio to the TBP housekeeping gene RNA level. The results are expressed in arbitrary units and are represented after logarithm conversion. Relationship among the variables was evaluated by simple correlation analysis with the nontransformed values (r, Pearson correlation coefficient).
proMBP, recently identified as a physiological inhibitor of PAPP-A activity, is involved in the modulation of intrafollicular IGFBP-4 degradation (21) .
The intrafollicular degradation of IGFBP-4 by PAPP-A is closely conserved in preovulatory follicles of all the mammalian species studied. So one may hypothesize that degradation of IGFBP-4 has dramatic consequences on follicular maturation. Interestingly, very recent data have shown that as early as day 2 of the first follicular wave in cattle (at the beginning of luteal phase), IGFBP-4 proteolytic activity is higher in dominant in comparison with largest subordinate follicles, suggesting a role for the IGFBP-4 protease in the establishment of ovarian follicular dominance (48, 49) . First, intrafollicular cleavage of IGFBP-4 could participate to the increase in bioavailability of IGFs that further stimulate granulosa cell proliferation and steroidogenesis (50 -52) . Moreover, it is possible that IGFBP-4 proteolytic fragments have an IGF-independent effect on follicular cells. PAPP-A could play a key role in ovarian follicles as well and particularly could participate in oocyte maturation. Finally, the increase in PAPP-A expression level in ovary coincides with dramatic proteolytic events associated with ovulation involving plasmin, matrix metalloproteases and tissue inhibitors of metalloproteases (53) . It is possible that PAPP-A participates in ovulation by cleaving critical substrates.
We located the porcine PAPP-A gene to chromosome 1 (1q29 -1q213). The human PAPP-A gene has been located to chromosome 9q33.1 by fluorescence in situ hybridization (54) , and these two chromosomal regions have been shown to correspond to each other (55) .
In summary, we have shown that PAPP-A is involved in IGFBP-4 degradation in ovine, bovine, porcine, and equine preovulatory follicles. For the first time, we have shown that PAPP-A mRNA is expressed by granulosa cells of these four mammals. In bovine and porcine ovary, PAPP-A expression is positively correlated with expression of both aromatase and LH receptors. Factors regulating the expression of PAPP-A mRNA in granulosa cells as well as biological consequences of PAPP-A expression and IGFBP-4 cleavage in preovulatory follicles remain to be determined. Transcript levels of the target genes were normalized on the basis of the content of the endogenous control gene PO or TBP. Correlations were considered significant when P Ͻ 0.05.
a Ratio transcript level (arbitrary unit).
